Biosimilar Product Development: Regulatory Challenges & Key Insights
In this era where the demand for affordable healthcare is increasing every day, biosimilars that are replacements for biologics have […]
Expected Patent Expiry Drugs List: Top Drugs Losing Patent Protection By 2030
Over the years, many top drugs have witnessed its growth and development due to its novelty. But as the patent
Document Management Systems (DMS) for Pharmaceutical Industry
A 21 CFR Part 11 compliance DMS is part of overall compliance and quality requirements across pharmaceutical organizations. Many tools
Bioconjugates: Combining the Best of Biologics and Small Molecules
Bioconjugates are molecules formed by chemically linking two or more molecules, typically involving a biological molecule like a protein, enzyme,
Biosimilars vs. Generics: Key Differences and Market Implications
In pharmaceuticals, biosimilars and generics are two important categories that often come up in discussions about drug affordability and accessibility.
Drug Master File (DMF): Meaning, Submission & Guidelines
The critical information about the CMC (Chemistry, Manufacturing and Control) aspect of an active pharmaceutical ingredient or a finished pharmaceutical
What Is Investigational New Drug & Types Of IND
The governing federal law makes it a compulsion for the pharmaceuticals to be subject to the marketing application for their
Import of Biological Specimens into India
A Biological specimen is a pharmaceutical product prepared by utilizing living cells and tissues to prevent, diagnose, or treat diseases.
Top 11 Regulatory Information Management Software
Demand for regulatory information management software is growing due to increasing compliance requirements from health authorities, such as XEVMPD, IDMP,